Total planned funding: $616,871,151
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $116,110,741 |
South Africa | $88,900,528 |
Kenya | $65,020,323 |
Tanzania | $55,105,651 |
Nigeria | $49,516,971 |
Zambia | $44,934,904 |
Malawi | $37,597,386 |
Uganda | $29,502,706 |
Botswana | $22,563,854 |
Côte d'Ivoire | $17,060,683 |
Namibia | $15,610,728 |
Ethiopia | $14,583,000 |
Eswatini | $12,067,591 |
Haiti | $11,622,125 |
Democratic Republic of the Congo | $10,154,812 |
Lesotho | $7,927,418 |
South Sudan | $4,747,655 |
Rwanda | $3,895,756 |
Guyana | $2,990,000 |
Ukraine | $2,450,000 |
Vietnam | $2,396,851 |
Zimbabwe | $1,361,468 |
Burundi | $600,000 |
Ghana | $150,000 |
Cameroon | $0 |
Organizational Types
University | $616,871,151 |
Program Areas
Treatment | $168,137,811 |
Prevention | $155,047,254 |
Care | $67,831,236 |
Governance and Systems | $48,080,604 |
Testing | $46,977,159 |
Management and Operations | $210,000 |
Budget Codes
HTXS: Treatment: Adult Treatment | $145,563,737 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $98,905,914 |
HVCT: Testing: HIV Testing and Counseling | $46,977,159 |
HVOP: Sexual Prevention: Other Sexual Prevention | $29,658,504 |
HBHC: Care: Adult Care and Support | $25,482,259 |
HVSI: Strategic Information | $22,722,199 |
PDTX: Treatment: Pediatric Treatment | $22,474,074 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $18,269,487 |
OHSS: Health Systems Strengthening | $15,353,060 |
HVTB: Care: TB/HIV | $14,958,312 |
HKID: Care: Orphans and Vulnerable Children | $14,310,326 |
PDCS: Care: Pediatric Care and Support | $13,080,339 |
HLAB: Laboratory Infrastructure | $10,005,345 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,415,169 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $948,881 |
HMBL: Biomedical Prevention: Blood Safety | $488,049 |
HMIN: Biomedical Prevention: Injection Safety | $361,250 |
HVMS: Management and Operations | $210,000 |
HTXD: Treatment: ARV Drugs | $100,000 |
Top Partner Programs
Johns Hopkins University:
$198,645,586
View countries